GCP
AMPE

GSA Capital Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

GSA Capital Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,865
Closed -$314K – 1830
2019
Q1 		$314K Sell
1,865
-354
-16% -$60.6K 0.03% 960
2018
Q4 		$263K Buy
+2,219
New +$341K 0.03% 916
2018
Q3 		– Sell
-75
Closed -$49K – 1996
2018
Q2 		$49K Buy
+75
New +$56.1K ﹤0.01% 1623

Other funds holding AMPE

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GSA Capital Partners's AMPE Position: Q2 2019 in Review

GSA Capital Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2019, closing a stake of 1,865 shares — an estimated $314K sold.

GSA Capital Partners first reported a position in AMPE in Q2 2018 and held it in 3 quarters. The position peaked at $314K in Q1 2019. 81 funds tracked by Wall St. Rank hold AMPE as of Q2 2019.

  • GSA Capital Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • GSA Capital Partners sold 1,865 Ampio Pharmaceuticals Inc. shares in Q2 2019, an estimated $314K.
  • GSA Capital Partners first reported a position in Ampio Pharmaceuticals Inc. in Q2 2018 and held it in 3 quarters.
  • GSA Capital Partners's Ampio Pharmaceuticals Inc. position peaked at $314K in Q1 2019.
  • 81 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2019.

Based on GSA Capital Partners's 13F filing for Q2 2019, filed 6 Aug 2019.